Compare Cardinal Health Inc (CAH) vs SiTime Corporation (SITM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs SiTime Corporation — how do they compare? Cardinal Health Inc trades at $234.16 (market cap $55.88B), while SiTime Corporation trades at $679.01 (market cap $20.05B). The key difference: Cardinal Health Inc is far larger — about 2.8× SiTime Corporation's market cap, and Cardinal Health Inc pays a 0.86% dividend while SiTime Corporation pays none. Which is the better fit depends on your goals.
| CAH | SITM | |
|---|---|---|
Market Cap | $55.88B | $20.05B |
Sector | Health | Technology |
52-Week High | $240.26 | $901.60 |
52-Week Low | $146.04 | $212.77 |
Enterprise Value | $59.91B | $19.45B |
Dividend Yield | 0.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $235.3, down 0.79% on the day, but remains near its 52-week high. The stock exhibits a bullish technical signal with consistent earnings beats in recent quarters, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue for fiscal 2025 was $222.58 billion, with net income reaching $1.56 billion. Analyst consensus is strongly positive, with 18 buys and a $266.43 price target, reflecting confidence in the company's pharmaceutical and specialty business growth.
The outlook for CAH is favorable, driven by robust earnings performance and optimistic fiscal 2027 guidance. Key opportunities include sustained demand for specialty drugs and operational efficiency gains. Risks involve high debt levels, with a debt-to-asset ratio of 16.09 in 2025, and competitive pressures in the healthcare distribution sector. Investors should weigh strong analyst support against balance sheet leverage and market volatility.
SITM trades at $680.52, down 1.37% on the day, with a bullish technical outlook supported by moving averages and key resistance at $687. The company reported strong Q2 2026 earnings of $2.34 per share, beating estimates, with revenue surging 127% year-over-year driven by AI infrastructure demand. Analyst consensus is unanimously bullish with a $870 price target, reflecting optimism around the Renesas acquisition and AI timing growth.
The outlook for SITM is positive given robust earnings beats, AI-driven revenue expansion, and solid institutional support. However, risks include premium valuation multiples, integration challenges from the Renesas deal, and dependence on cyclical tech spending. Investors should weigh high growth potential against execution risks in a competitive semiconductor market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About SiTime Corporation
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →
